Elevated Serum Creatinine: Diagnosis and Management

Introduction to Elevated Serum Creatinine

Elevated serum creatinine is a primary indicator of reduced glomerular filtration rate (GFR) and kidney dysfunction, as indicated by the Journal of Clinical Oncology and Kidney International 1, 2
Creatinine levels are used to diagnose and classify the severity of acute kidney injury (AKI) and chronic kidney disease (CKD), according to Hepatology and European Heart Journal 3, 4

A rise in serum creatinine of ≥0.3 mg/dL within 48 hours or ≥50% increase within 7 days indicates acute kidney injury, as stated by Hepatology and Clinical Gastroenterology and Hepatology 3, 5
Values of estimated GFR below 60 ml/min/1.73 m² indicate chronic kidney disease stage 3, while values below 30 and 15 ml/min/1.73 m² indicate stages 4 and 5, respectively, according to European Heart Journal 4, 6
The American Diabetes Association recommends optimizing blood pressure control and considering ACE inhibitors or ARBs for patients with diabetes and albuminuria 9
The European Society of Cardiology suggests that a slight increase in serum creatinine (up to 20%) may occur when antihypertensive therapy is initiated but should not be taken as a sign of progressive renal deterioration 4, 6

The American College of Cardiology recommends considering temporarily holding potentially nephrotoxic medications for mild elevation (1.5-2.0 times baseline) 1, 7
For moderate elevation (2-3 times baseline), the National Kidney Foundation suggests holding nephrotoxic medications and considering nephrology consultation 1, 7
In cases of severe elevation (≥3 times baseline or ≥4.0 mg/dL), the European Renal Association recommends hospitalization and urgent nephrology consultation 1, 7
For life-threatening elevation (requiring dialysis), the International Society of Nephrology recommends immediate hospitalization and nephrology consultation, and evaluating for all potential causes 1, 7

The American Heart Association recommends not discontinuing ACE inhibitors or ARBs for minor increases in serum creatinine (≤30%) in the absence of volume depletion 9
The European Association for the Study of the Liver suggests evaluating for hepatorenal syndrome and considering vasoconstrictors plus albumin for patients with cirrhosis and elevated creatinine 5
The National Institute of Diabetes and Digestive and Kidney Diseases recommends monitoring patients with a history of AKI at 3 months for resolution or progression to CKD 2